1. Home
  2. |Insights
  3. |Federal Circuit Opinion on Heart Medication May Raise Generics' Blood Pressure

Federal Circuit Opinion on Heart Medication May Raise Generics' Blood Pressure

Client Alert | less than 1 min read | 10.08.20

Insights

Client Alert | 3 min read | 11.12.25

EPA Proposes Important Revisions to its PFAS Reporting Regulations

On November 10, 2025, the U.S. Environmental Protection Agency (EPA) released proposed regulations that, if adopted, would substantially alter the reporting obligations of companies that manufacture or import products containing per- or polyfluoroalkyl substances (PFAS). The proposed regulations would significantly reduce reporting burdens by exempting numerous products that currently trigger reporting requirements under EPA’s PFAS reporting regulations.  The proposed regulations would also delay the current deadline for reporting....